Clinical Trials
4 trialsNCT04809467 2026-02-04
topMIND
Incyte Corporation
Phase 1/2 Terminated
NCT02998476 2025-08-22
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)
Incyte Corporation
Phase 2 Completed
NCT03235544 2025-03-18
(CITADEL-205)
Incyte Corporation
Phase 2 Completed
NCT03126019 2025-03-14
CITADEL-203
Incyte Corporation
Phase 2 Completed